EMA committee recommends marketing approval of Pfizer & BioNTech’s LP.8.1-adapted Covid-19 vaccine: New York Saturday, July 26, 2025, 10:00 Hrs [IST] Pfizer Inc. and BioNTech SE ...

Pfizer-BioNTech's COVID-19 vaccine appears to be safe and effective for children ages 6 months to 5 years, ... No new safety concerns were identified during the trial, ...

Scientists in Turkey found that the Pfizer COVID-19 vaccine impacted some people's corneas, according to a study.

Researchers looked at how the vaccine affected patients' corneas - the clear front part of the eye that allows light to come ...

Data indicate that the LP.8.1-adapted COVID-19 vaccine confers improved immune response against currently dominant and emerging sublineages – including the XFG and NB.1.8.1 variants1 – compared to 202 ...

Pfizer CEO Dr. Albert Bourla joined “GMA3: What You Need To Know” Monday to discuss the drug-maker's coronavirus vaccine after early analysis shows it to be 90% effective at preventing COVID-19.

Pfizer is the first drug company to release data from a large Phase 3 trial for a coronavirus vaccine designed to show both effectiveness and safety. Hotspots ranked Start the day smarter ☀️ ...

In a promising development, an initial glimpse at the data from Pfizer's ongoing late-stage clinical trial shows that the company's vaccine is more effective at preventing COVID-19 than placebo.

An expert panel of the EU drug regulator, the European Medicines Agency (EMA) on Friday recommended marketing authorizations ...

Pfizer has accumulated enough safety data on its Covid-19 vaccine and is preparing to file for emergency use authorization from the US Food and Drug Administration, company CEO Albert Bourla said ...

A two-shot coronavirus vaccine developed by Pfizer and German firm BioNTech appears to be on the cusp of regulatory clearance, after a 53-page review published Tuesday confirmed that the vaccine ...

London — U.S. drugmaker Pfizer said Monday that human trials suggest its coronavirus vaccine is 90% effective at preventing COVID-19 infections in people not known to have had the virus already.